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The worldwide prevalence of maintenance hemodialysis continues to rise. An adequate delivery of hemodialysis dose as measured
by Kt/V or urea reduction ratio is a crucial determinant of clinical outcome for chronic hemodialysis patients. The aim of this
study was to assess the adequacy of hemodialysis and its associated factors among patients undergoing chronic hemodialysis in
Dar es Salaam. This was a cross-sectional study done on patients undergoing chronic hemodialysis in four dialysis centers in Dar
es Salaam. Sociodemographic information and treatment characteristics were collected. Urea reduction rate and single-pool Kt/V
were calculated to determine the adequacy of hemodialysis. The data were analyzed and any associated factors for inadequate
hemodialysis were determined using a chi-square test and a logistic regression analysis. A total of 143 patients participated in the
study. Males represented 65.7% of the study population. The mean age (±SD) was 51.7 ± 1.2 years. Only 34.3% (based on urea
reduction ratio (URR)) and 40.6% (based on Kt/V) of patients received adequate hemodialysis. The univariate analysis showed
that males were more likely to have inadequate dialysis (65.6% versus 48.0%, p � 0.048 based on Kt/V). Patients using
hemodialyzers with dialyzer surface area less than 1.4 m2 received signiﬁcantly less hemodialysis dose than those with more than
1.4 m2 (69.0% versus 41.2%, p � 0.02, by URR) (62.7% versus 35.3%, p � 0.03, by Kt/V criteria). Patients who had hemoglobin
<10 g/dl received signiﬁcantly inadequate hemodialysis dose as compared to patients with hemoglobin ≥10 g/dl by Kt/V criteria
(69.8% versus 51.3%, p � 0.03). None of the factors acquired signiﬁcance in the multivariate analysis. The proportion of patients
receiving an adequate hemodialysis dose is low (34.3% based on URR and 40.6% based on Kt/V). Male gender, dialyzer surface
area of <1.4 m2, and hemoglobin level of <10 g/dl were associated with an inadequate delivered dose of hemodialysis in the
univariate analysis but not in the multivariate analysis. This study can increase awareness about the importance of measuring
hemodialysis adequacy and giving the correct hemodialysis dose to achieve the intended beneﬁt.

1. Introduction
Chronic kidney disease (CKD) has nearly doubled as a cause
of death worldwide between 1990 and 2010 and was the 18th
highest cause of death worldwide in 2010 [1]. It is estimated
that by 2030 more than 70% of patients with end-stage renal
disease will be living in low-income countries, such as those
in Sub-Saharan Africa. In Kinshasa, the prevalence of CKD
was found to be 12.4% among adults in the general population. In Uganda, 20% of HIV/AIDS patients had
CKD [2, 3]. There are many potential causes of CKD in

Sub-Saharan Africa which makes kidney disease burdensome
in the region. In addition to noncommunicable diseases,
communicable diseases such as infectious glomerulonephritis,
schistosomiasis, leishmaniasis, and HIV infection are common
and can cause CKD [4, 5].
Patients with end-stage renal disease (ESRD) are unable to
sustain life without dialysis support. Hemodialysis is the
transport process by which a solute passively diﬀuses down its
concentration gradient from one ﬂuid compartment (either
blood or dialysate) into the other [6]. The goal of hemodialysis
is exiting of the toxins from the body and preservation of its
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intracellular and extracellular composition in normal range as
much as possible. The worldwide prevalence of long term
dialysis continues to rise [7, 8] driven in part by strong trends
towards the initiation of dialysis earlier in the natural history of
CKD than was the practice previously [9].
The adequacy of hemodialysis refers to how well toxins and
waste products are removed from the patient’s blood and has a
major impact on their well-being. Dialysis delivery should be
adequate to improve adequacy of life and to prolong survival
[10]. Studies have indicated an increase in morbidity and
mortality among patients with inadequate dialysis [11].
The urea removal indexes help to calculate the adequacy of
hemodialysis. The urea removal indexes include urea reduction
ratio (URR), single-pool (spKt/V), equilibrated (eKt/V), and
the weekly standard index (std Kt/V). This study used URR and
spKt/V to calculate hemodialysis adequacy.
1.1. Urea Reduction Ratio (URR) Index. The URR can be
assessed by measuring the blood urea nitrogen (BUN) level
before and after dialysis (8). It is calculated as follows:
(predialysis BUN − postdialysis BUN)
URR �
.
(1)
(predialysis BUN) × 100%

1.2. Single-Pool Index (spKt/V). The spKt/V index is deﬁned
as the amount of serum that is cleared from urea via the
distribution volume, in relation to the urea reduction ratio
during hemodialysis. Parameter K is the dialyzer blood water
urea clearance that is provided by the ﬁlter (measured as
liters per hour), t is the duration of the hemodialysis session
in hours, and V is the volume of urea distribution in
combination with the body water in liters.
The parameters spKt/V and URR are connected mathematically as follows:
spKt
(2)
� − ln(1 − URR),
V
where ln stands for natural logarithm.
In addition, the spKt/V index counts the ultraﬁltration
and the urea production. However, none of the parameters
surpass the other as a denouement criterion (9–12).
The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) 2006 guidelines
recommend spKt/V > 1.2 or URR ≥ 65% for maintenance
hemodialysis, when a three times per week hemodialysis
program is applied. These values constitute the lowest
possible values and not the target values, which are 1.4 for
spKt/V and 70% for URR.
No previous studies have been done to determine the
adequacy of hemodialysis in Dar es Salaam. Since the cost of
hemodialysis is high and entails signiﬁcant patient time, it is
important that hemodialysis should be done adequately.
There are approximately 300 patients who are undergoing
hemodialysis in Dar es Salaam.
This study was aimed at determining the adequacy of
hemodialysis and its associated factors in patients undergoing
chronic hemodialysis in Dar es Salaam. Findings from this
study will provide important feedback information to the
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dialysis centers in Dar es Salaam which can serve to improve
dialysis services in the region. Furthermore, this study built
awareness among the dialysis centers who were not already
measuring the adequacy of hemodialysis for their patients.

2. Materials and Methods
This was a cross-sectional study carried out in four dialysis
centers in Dar es Salaam, which included Muhimbili National Hospital, TMJ Hospital, Aga Khan Hospital, and
Tumaini Hospital. The ﬁnite sample size was 143. Data were
collected over a period of seven months. The study population included all consenting adults ≥18 years of age
undergoing chronic hemodialysis who were in a steady state
at the time of data collection. All patients had an average
dialysate ﬂow rate of 500 ml/min.
The measurement of blood urea before and after dialysis
was done for previous month in the ﬁrst week of the next
month. The calculation of URR and spKt/V was done using the
formulas described above. Relevant data on sociodemographics
and treatment characteristics were collected using structured
questionnaires and patient’s hospital records.
Urea after dialysis was taken following KDOQI guidelines as follows:
(1) The ultraﬁltration rate was set to zero.
(2) The blood pump was slowed to 100 ml per minute for
10–20 seconds.
(3) The pump was then stopped.
(4) A sample was drawn, either from arterial blood line
sampling port or from the tubing attached to arterial
needle.
Data were analyzed using SPSS 23. Relevant frequencies
and appropriate tables were generated for diﬀerent variables.
Means and proportions were calculated for appropriate variables. All associated factors for inadequate dialysis were analyzed using Chi-squared test. A logistic regression analysis was
done to ﬁnd out independent associating factors for inadequate
hemodialysis. Statistical signiﬁcance was set at p value < 0.05.
Permission to conduct the study was sought from relevant
ethical committees at MNH and Muhimbili University of Health
and Allied Sciences (MUHAS) (Ref no. MU/PGS/SAEC/Vol.
XIV). Permission from the dialysis centers was also sought.
All patients were entered into the study after an informed consent, either given by the patients themselves or
their guardians in the case where patients were not able to.
The data obtained during the study were kept anonymous.

3. Results
3.1. Social Demographic and Clinical Characteristics (Table 1).
A total of 143 participants were enrolled in the study. About
two-thirds (65.7%) were males. The mean age (±SD) was
51.7 ± 1.2 years.
3.2. Proportion of Patients Receiving Inadequate
Hemodialysis. The mean URR and Kt/V were 60.9 ± 12.0%
and 1.1 ± 0.3, respectively. The proportion of patients
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Table 1: Sociodemographic characteristics of the study population.
Characteristics
Age (years)
<40
≥40
Sex
Male
Female
Marital status
Married
Widowed
Divorced
Single
Education level
No formal education
Primary
Secondary
College/University
Body mass index (kg/m2)
Underweight (<18.5)
Normal (18.5–24.9)
Overweight (25–29.9)
Obese (>30)

Frequency (n � 143)

Percent (%)

27
116

18.9
81.1

94
49

65.7
34.3

102
14
9
18

71.3
9.8
6.3
12.6

5
33
62
43

3.5
23.1
43.3
30.1

14
81
40
8

9.8
56.6
28.0
5.6

receiving adequate hemodialysis among patients undergoing
chronic hemodialysis in Dar es Salaam based on URR was
34.3% and based on Kt/V was 40.6%.
By Kt/V criteria, males had signiﬁcantly a higher
prevalence of inadequate hemodialysis (65.6% versus 48.0%,
p � 0.048) but not by URR criteria (70.2% versus 57.1%,
p � 0.139)(Table 2).
Patients using a dialyzer surface area of less than 1.4 m2
had signiﬁcantly more inadequate hemodialysis as compared to those with dialyzer surface area ≥1.4 m2 (69.0%
versus 41.2%, p � 0.023, by URR criteria) (62.7% versus
35.3%, p � 0.033, by Kt/V criteria) (Table 3).
By Kt/V criteria, patients who had hemoglobin of <10 g/
dl in the last month had signiﬁcantly more inadequate
hemodialysis as compared to those who had hemoglobin of
≥10 g/dl. This association was not seen when using URR
criteria (71.4% versus 61.3%, p � 0.203, by URR criteria)
(69.8 versus 51.3%, p � 0.029, by Kt/V criteria) (Table 3).
The logistic regression analysis was done to ﬁnd independent association of factors with inadequate hemodialysis
in patients undergoing chronic hemodialysis in Dar es Salaam. Factors that showed association in univariate analysis
were included in the regression model. None of the factors
showed independent association with inadequate hemodialysis in patients undergoing chronic hemodialysis by both
URR and Kt/V (Table 4).

4. Discussion
This was a cross-sectional study looking at the prevalence of
inadequate dialysis and its associated factors.
In this study, the mean Kt/V was 1.1 and URR was 60.9%.
This indicated that generally patients achieve less than the
hemodialysis target therapy as per NKF-KDOQI 2006
recommendations [16]. These values were however better

than the values reported in Iran (Kt/V � 0.93, 1.17 and
URR � 53%) [17, 18]. This study revealed similar ﬁndings to
those carried out in other developing countries such as
Brazil, Nigeria, Nepal, and Pakistan [19–23] but they diﬀered
from those reported from developed countries such as the
United States [24] and from other ﬁve European countries as
part of the DOPPS study where the mean delivered Kt/V
varied from 1.28 to 1.50 [25].
In this study, it was found that about one-third (34.3%)
and 40.6% receive target URR (≥65%) and Kt/V (>1.2),
respectively. Similar values for URR and Kt/V were found in
studies done in Sari [26] and Rasht states and in Qom
[27, 28]. A study in Ardabil showed that only 10% of patients
received adequate hemodialysis [29]. This was in contrast to
studies done in developed countries (DOPPS study and in
the United States) where URR ranged from 60–90% and Kt/
V was more than 1.2 [24, 25]. The substantial discrepancy in
hemodialysis adequacy between developed and developing
regions may be resulting from the more frequent use of highﬂux dialysis and higher blood ﬂow rates in the developed
countries than in the developing regions like Dar es Salaam
(19–60% versus 0.0%, and 251–322 ml/min versus 269 ml/
min, respectively) [24, 25]. Some centers in Dar es Salaam do
not adequately follow the KDOQI guidelines and this could
have resulted in the lower proportion of adequate
hemodialysis.
This study found three factors that were signiﬁcantly
associated with inadequate dialysis in the univariate analysis.
Males were more likely to have inadequate hemodialysis
than females. These results were similar to a study done in
Iran where they found that males had three times more
inadequate hemodialysis as compared to females [17]. Since
the dialysis eﬃciency is inversely proportional to the urea
distribution volume (V), it is expected that patients with
higher values of height will have less dialysis eﬃciency and
this may at least in part explain the diﬀerence as men are
generally taller than women. It may also be due to less
muscular mass, less body activity, and better diet observance
among females [28].
This study also found that patients using hemodialyzers
with surface area less than 1.4 m2 received signiﬁcantly less
hemodialysis dose than those who used dialyzers with
surface area of more than or equal to 1.4 m2. Hemodialyzers
with smaller surface area are known to give less adequate
hemodialysis than those having larger surface area. This was
shown in a study done in Bangladesh where they found that
increasing the surface area of a dialyzer membrane (from 1.2
to 1.3 m2) increased the adequacy of hemodialysis by 10.4%
(by URR criteria) and 19.7% (by Kt/V criteria) [30]. Similarly, Panagoutsos et al. showed that increasing the surface
area of the dialyzer membrane from 1.15 m2 ± 0.1 to 1.7 m2
increased the Kt/V from 0.93 ± 0.19 to 1.55 ± 2.9 (p < 0.05)
and URR from 52 ± 8% to 71 ± 7% (p < 0.05); that is, there
was 66.7% and 36% increment in Kt/V and URR, respectively [31].
This study also found that patients with hemoglobin of
less than 10 g/dl had more inadequate hemodialysis as
compared to those who had hemoglobin of 10 g/dl. A study
in South Africa showed that increasing the dose of
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Table 2: Demographic and clinical factors associated with inadequate hemodialysis.
Factors

Age (years)
<40
≥40
Sex
Male
Female
Education level
No formal education
Primary
Secondary
College/University
Body mass index (kg/m2)
Underweight (<18.5)
Normal (18.5–24.9)
Overweight (25–29.9)
Obese (>30)
Underlying disease
Hypertension alone
Diabetes alone
Hypertension and diabetes
Others

URR
Inadequate (%)
Adequate (%)

p value

Kt/V
Inadequate (%)
Adequate (%)

p value

19 (70.4)
75 (64.7)

8 (29.6)
41 (35.3)

0.657

15 (55.6)
69 (59.5)

12 (44.4)
47 (40.5)

0.435

66 (70.2)
28 (57.1)

28 (29.8)
21 (42.9)

0.139

61 (65.6)
24 (48.0)

32 (34.4)
26 (52.0)

0.048

3 (60.0)
21 (63.6)
39 (62.8)
31 (72.1)

2 (40.0)
12 (36.4)
23 (37.2)
12 (27.9)

0.741

3 (60.0)
20 (58.8)
35 (57.4)
27 (62.8)

2 (40.0)
14 (41.2)
26 (42.6)
16 (37.2)

0.957

10 (71.4)
54 (66.7)
25 (62.5)
5 (62.5)

4 (28.6)
27 (33.3)
15 (37.5)
3 (37.5)

0.932

10 (66.7)
48 (59.3)
22 (56.4)
5 (62.5)

5 (33.3)
33 (40.7)
17 (43.6)
3 (37.5)

0.963

54 (64.3)
11 (57.9)
20 (66.7)
9 (90.0)

30 (35.7)
8 (42.1)
10 (33.3)
1 (10.0)

0.381

48 (57.1)
10 (55.6)
19 (63.3)
7 (70.0)

36 (42.9)
8 (44.4)
11 (36.7)
3 (30.0)

0.832

Table 3: Treatment characteristics associated with inadequate hemodialysis.
URR
Inadequate (%)
Adequate (%)
Dialyzer surface area (m2)
<1.4
87 (69.0)
39 (31.0)
≥1.4
7 (41.2)
10 (58.8)
Vascular access in the last month∗
Temporary
27 (71.1)
11 (28.9)
Permanent
67 (63.8)
38 (36.2)
Months since dialysis initiation
3–12
53 (63.1)
31 (36.9)
>12
41 (69.5)
18 (30.5)
Number of dialysis sessions per week
1
0
2 (100.0)
2
15 (62.5)
9 (37.5)
3
79 (67.5)
38 (32.5)
Dialysis sessions in a month
2–11
32 (60.4)
21 (39.6)
>11
62 (68.9)
28 (31.1)
Blood ﬂow rate (ml/min)
<250
13 (65.0)
7 (35.0)
≥250
81 (65.9)
42 (34.1)
Ultraﬁltration (liters)
0–2
65 (65.7)
34 (34.3)
2–4
29 (65.9)
15 (34.1)
Hemoglobin (g/dL)
<10
45 (71.4)
18 (28.6)
≥10
49 (61.3)
31 (38.7)
Factors

∗

p value

Kt/V

p value

Inadequate (%)

Adequate (%)

0.023

79 (62.7)
6 (35.3)

12 (31.6)
46 (43.8)

0.033

0.420

26 (68.4)
59 (56.2)

12 (31.6)
46 (43.8)

0.226

0.428

48 (57.1)
37 (62.7)

36 (42.9)
22 (37.3)

0.467

0.128

0
15 (62.5)
70 (59.8)

2 (100.0)
9 (37.5)
47 (40.2)

0.222

0.300

31 (58.5)
54 (60.0)

22 (41.5)
36 (40.0)

0.901

0.941

13 (65.0)
72 (58.5)

7 (35.0)
51 (41.5)

0.566

1.000

60 (60.6)
25 (56.8)

39 (39.4)
19 (43.2)

0.716

0.203

44 (69.8)
41 (51.3)

19 (30.2)
39 (48.7)

0.029

Temporary access included central venous catheters and permanent access included arteriovenous ﬁstulae and arteriovenous graft in 3 patients.

hemodialysis from a Kt/V of 0.8 to 2 increased the hemoglobin level from 8.5 g/dl to more than 10 g/dl [32]. The
inadequate urea clearance by hemodialysis can result in
malnutrition, anemia, and functional impairment with an

increased risk of hospitalization, morbidity, and mortality.
Anemia could also be a marker for inﬂammation and
malnutrition, which can inﬂuence Kt/V, but this was not
evaluated in this study.
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Table 4: Logistic regression analysis for factors with inadequate
hemodialysis.
Characteristic
By URR
Sex—male
Hb < 10 g/dLb
DSA < 1.4 m2c
By Kt/V
Sex—malea
Hb < 10 g/dLb
DSA < 1.4 m2c

Adjusted OR

95% CI

p value

0.58
0.67
1.58

0.28–1.20
0.33–1.38
0.54–4.60

0.144
0.278
0.402

0.49
0.49
1.23

0.24–1.00
0.24–1.00
0.41–3.72

0.050
0.050
0.708

a: versus females; b: versus Hb > 10 g/dL; c: versus DSA > 1.4 m2.

The logistic regression analysis failed to show any signiﬁcant association between the above factors with hemodialysis adequacy. This probably indicates that hemodialysis
adequacy is not dependent on one variable alone, but rather
it is a function of diﬀerent factors.
Strengths of this study were that it was a multicenter study
which enabled participants from diﬀerent backgrounds to be
included. Many factors were evaluated for them associated with
hemodialysis adequacy. Furthermore, hemodialysis adequacy
was assessed using both Kt/V and URR.
The study had a few limitations. Firstly, the investigations for diﬀerent patients were done at their respective
centers which may have brought some variability in the
results. Data on some confounding factors for Kt/V were not
collected in this study such as albumin, inﬂammatory
markers (CRP and ferritin), residual renal function, and
other comorbidities unrelated to CKD.

5. Conclusion
Hemodialysis inadequacy is frequent in Dar es Salaam and is
associated with male gender, dialyzer surface area, and
hemoglobin level. Giving the correct hemodialysis dose
could help improve hemodialysis adequacy.
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